Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.
Agurto-Arteaga A, Poma-Acevedo A, Rios-Matos D, Choque-Guevara R, Montesinos-Millán R, Montalván Á, Isasi-Rivas G, Cauna-Orocollo Y, Cauti-Mendoza MG, Pérez-Martínez N, Gutierrez-Manchay K, Ramirez-Ortiz I, Núñez-Fernández D, Salguedo-Bohorquez MI, Quiñones-Garcia S, Fernández Díaz M, Guevara Sarmiento LA, Zimic M; COVID-19 Working Group in Perú.
Agurto-Arteaga A, et al. Among authors: montalvan a.
Front Immunol. 2022 May 10;13:881604. doi: 10.3389/fimmu.2022.881604. eCollection 2022.
Front Immunol. 2022.
PMID: 35664008
Free PMC article.